HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM
Delisted
HTGM was delisted on the 14th of June, 2023.
23 hedge funds and large institutions have $7.34M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $18K
Holders
23
Holding in Top 10
–
Calls
–
Puts
$18K
Top Buyers
| 1 | +$1.67M | |
| 2 | +$123K | |
| 3 | +$109K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$51K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.5K |
Top Sellers
| 1 | -$802K | |
| 2 | -$169K | |
| 3 | -$132K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$130K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$63K |